Brief: Xilong Scientific's Unit Sells Stake In Biological Firm To Fulgent Investment Development
May 7 (Reuters) - Xilong Scientific Co Ltd 002584.SZ :
* SAYS UNIT AGREES TO SELL 40.5% STAKE IN GENETIC BIOLOGICAL
FIRM
FOR 122 MILLION YUAN ($18.93 million) TO FULGENT INVESTMENT
DEVELOPMENT LTD (HONG KONG)
Source text in Chinese: https://bit.ly/3nY87xS
Further company coverage: 002584.SZ
($1 = 6.4447 Chinese yuan renminbi)
(Reporting by Hong Kong newsroom)
((meg.shen@thomsonreuters.com; 852-39525805;))
Recent news on Fulgent Genetics
See all newsU.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay
Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview